SMTL ID : 9dms.1

Human muscle nAChR with fab6-bound

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-2-1-1-1-1-1-mer

Ligands

4 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.1: 10 residues within 4Å: Chain A: N.161, S.163, E.200, W.204, K.205, H.206, S.207, T.222, H.224, V.226 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:S.207, A:W.204, A:H.206 NAG-NAG-BMA-MAN-MAN.2: 10 residues within 4Å: Chain B: N.161, S.163, E.200, W.204, K.205, H.206, S.207, T.222, H.224, V.226 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.207, B:W.204, B:H.206 NAG-NAG-BMA-MAN-MAN.3: 15 residues within 4Å: Chain C: Q.154, W.162, N.164, T.166, R.216, I.218, I.236, Y.238, I.240, P.496, P.499, F.500, P.501, S.502, R.503 2 PLIP interactions: 2 interactions with chain C Hydrophobic interactions: C:I.218 Hydrogen bonds: C:P.501 NAG-NAG-BMA-MAN-MAN.4: 16 residues within 4Å: Chain D: W.162, N.164, R.219, N.221, V.222, D.223, P.224, R.225, T.237, Y.239, I.241, P.498, P.501, F.502, P.503, D.505 3 PLIP interactions: 3 interactions with chain D Hydrogen bonds: D:R.225, D:R.219, D:N.221, D:P.503

1 x NAG- NAG- BMA- MAN- BMA: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-BMA.5: 11 residues within 4Å: Chain E: W.159, N.161, S.163, V.213, R.215, H.217, I.231, S.233, I.235, P.483, L.485 4 PLIP interactions: 4 interactions with chain E Hydrophobic interactions: E:V.213, E:R.215, E:I.231 Hydrogen bonds: E:R.215

5 x CLR: CHOLESTEROL(Non-covalent)

CLR.6: 8 residues within 4Å: Chain B: V.291, K.296, L.299, F.300, V.303, F.304 Chain D: L.247, I.251 5 PLIP interactions: 4 interactions with chain B, 1 interactions with chain D Hydrophobic interactions: B:V.291, B:F.300, B:F.300, B:V.303, D:L.247 CLR.10: 10 residues within 4Å: Chain D: V.258, F.262, V.482, T.485, A.486, F.489, L.490, V.493, Y.494 Ligands: CLR.11 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.262, D:F.262, D:V.482, D:T.485, D:F.489, D:L.490, D:L.490, D:V.493 CLR.11: 11 residues within 4Å: Chain D: F.160, P.246, I.250, L.254, V.255, V.258, L.259, F.262, F.489, V.493 Ligands: CLR.10 10 PLIP interactions: 10 interactions with chain D Hydrophobic interactions: D:F.160, D:F.160, D:I.250, D:I.250, D:L.254, D:V.255, D:V.258, D:F.489, D:V.493, D:V.493 CLR.13: 10 residues within 4Å: Chain E: T.153, Y.154, S.300, V.301, R.306, F.310, G.469, L.472, I.473 Ligands: CLR.14 2 PLIP interactions: 2 interactions with chain E Hydrophobic interactions: E:T.153, E:I.473 CLR.14: 11 residues within 4Å: Chain B: L.232, V.236, I.240 Chain E: L.299, S.300, V.301, R.306, I.309, F.310, V.313 Ligands: CLR.13 4 PLIP interactions: 3 interactions with chain E, 1 interactions with chain B Hydrophobic interactions: E:V.301, E:I.309, E:V.313, B:L.232

4 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)

POV.7: 15 residues within 4Å: Chain C: L.246, L.249, V.250, I.253, A.254, I.257, F.487 Chain D: T.156, A.305, I.306, K.311, L.314, F.315, V.318, L.319 10 PLIP interactions: 3 interactions with chain C, 7 interactions with chain D Hydrophobic interactions: C:A.254, C:I.257, C:F.487, D:I.306, D:K.311, D:L.314, D:F.315, D:F.315, D:V.318 Hydrogen bonds: D:I.306 POV.9: 18 residues within 4Å: Chain C: L.261, F.265, Y.268, K.361, R.469 Chain D: M.322, V.325, I.326, I.329, I.333, R.336, H.341, V.347, F.351, W.462, V.465, V.469, C.473 9 PLIP interactions: 6 interactions with chain D, 3 interactions with chain C Hydrophobic interactions: D:I.329, D:I.329, D:I.333, D:V.347, D:V.469, C:F.265, C:Y.268 Salt bridges: D:R.336, C:K.361 POV.15: 21 residues within 4Å: Chain A: L.299, V.303, I.306, A.307, I.310 Chain E: F.157, R.237, P.240, L.241, V.244, I.245, I.248, V.249, V.252, L.253, F.307, F.466, S.467, S.470, S.471, F.474 9 PLIP interactions: 8 interactions with chain E, 1 interactions with chain A Hydrophobic interactions: E:L.241, E:V.244, E:I.245, E:V.252, E:V.252, E:L.253, E:F.474, E:F.474, A:A.307 POV.16: 27 residues within 4Å: Chain A: I.306, I.310, V.313, I.314, N.317, R.321, H.326 Chain E: V.252, L.253, G.256, L.257, L.259, L.260, A.261, Y.262, F.263, L.264, P.265, A.266, K.272, V.325, N.452, D.455, F.459, W.460, L.463, F.466 14 PLIP interactions: 9 interactions with chain E, 5 interactions with chain A Hydrophobic interactions: E:V.252, E:L.259, E:L.260, E:F.263, E:F.263, E:F.263, E:F.459, E:F.466, A:I.310, A:I.314 Salt bridges: E:D.455, A:H.326 Hydrogen bonds: A:N.317, A:R.321

2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.8: 4 residues within 4Å: Chain B: R.46 Chain D: E.93, G.96, N.97 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:R.46 NAG.12: 5 residues within 4Å: Chain E: R.43, Y.83, N.86, G.133, G.134 1 PLIP interactions: 1 interactions with chain E Hydrophobic interactions: E:Y.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Li, H. et al., Structure of human muscle AChR with fab6-bound. To Be Published

Release Date

2025-04-09

Peptides

Acetylcholine receptor subunit alpha: AB
Acetylcholine receptor subunit beta: C
Acetylcholine receptor subunit delta: D
Acetylcholine receptor subunit epsilon: E
Fab6 heavy chain: F
Fab6 light chain: G

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
E

D
D

E
B

F
F

G
G

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Acetylcholine receptor subunit alpha

Acetylcholine receptor subunit beta

Acetylcholine receptor subunit delta

Acetylcholine receptor subunit epsilon

Fab6 heavy chain

Fab6 light chain

Related Entries With Identical Sequence